The drugmaker said the results for giredestrant open the door to adding a treatment option at an early stage of the cancer, ...

Roche's experimental oral drug giredestrant has been shown to cut the risk of recurrence of a common form of breast cancer ...

By embedding standardized questionnaires and algorithms into routine visits, providers can evaluate risk factors such as age, ...

Roche has reported another phase 3 win for its oral selective estrogen receptor degrader (SERD). Success at a planned interim ...

The rationale is really strong since we're often making decisions for our patients based on single features or ...

The second-line endocrine therapy landscape in hormone receptor (HR)-positive, HER2-negative advanced breast cancer is ...

Hello Beautiful,” the new drama about a model facing breast cancer, aims to rewrite Hollywood’s cancer stories.

Topline data were announced from a phase 3 trial evaluating giredestrant for the adjuvant treatment of estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative, ...

During a routine mammogram, doctors found something unusual in Patty Schone’s left breast. But the real danger was actually ...

A new law is providing better access to breast cancer screenings for Oklahomans. 2 News’ Naomi Keitt listened to experts to ...

A 4-year-old boy was diagnosed with a rare brain cancer, only five months before his mother was also diagnosed with cancer.

Last Thursday, dozens of Navassa residents, fire department trucks, and Santa took part in a parade for Heather McCain and ...